Ginkgo Bioworks Holdings Inc
NYSE:DNA
Income Statement
Earnings Waterfall
Ginkgo Bioworks Holdings Inc
Revenue
|
251.5m
USD
|
Cost of Revenue
|
-54m
USD
|
Gross Profit
|
197.5m
USD
|
Operating Expenses
|
-773.5m
USD
|
Operating Income
|
-576m
USD
|
Other Expenses
|
-316.8m
USD
|
Net Income
|
-892.9m
USD
|
Income Statement
Ginkgo Bioworks Holdings Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
133
N/A
|
197
+48%
|
314
+59%
|
438
+40%
|
539
+23%
|
528
-2%
|
478
-10%
|
390
-18%
|
326
-16%
|
315
-3%
|
251
-20%
|
|
Gross Profit | ||||||||||||
Cost of Revenue |
(56)
|
(77)
|
(130)
|
(191)
|
(238)
|
(241)
|
(204)
|
(141)
|
(95)
|
(78)
|
(54)
|
|
Gross Profit |
77
N/A
|
120
+57%
|
184
+53%
|
247
+34%
|
301
+22%
|
287
-5%
|
274
-5%
|
249
-9%
|
231
-7%
|
237
+3%
|
197
-17%
|
|
Operating Income | ||||||||||||
Operating Expenses |
(284)
|
(320)
|
(2 013)
|
(2 690)
|
(3 327)
|
(3 930)
|
(2 436)
|
(1 939)
|
(1 436)
|
(962)
|
(773)
|
|
Selling, General & Administrative |
(75)
|
(94)
|
(863)
|
(1 276)
|
(1 676)
|
(2 070)
|
(1 384)
|
(1 044)
|
(687)
|
(317)
|
(193)
|
|
Research & Development |
(209)
|
(226)
|
(1 150)
|
(1 414)
|
(1 652)
|
(1 860)
|
(1 053)
|
(895)
|
(750)
|
(645)
|
(581)
|
|
Operating Income |
(207)
N/A
|
(200)
+4%
|
(1 829)
-816%
|
(2 443)
-34%
|
(3 027)
-24%
|
(3 643)
-20%
|
(2 163)
+41%
|
(1 690)
+22%
|
(1 205)
+29%
|
(724)
+40%
|
(576)
+20%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
(17)
|
(72)
|
(90)
|
(94)
|
(139)
|
(104)
|
(77)
|
(48)
|
11
|
7
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
12
|
8
|
12
|
(14)
|
(47)
|
(68)
|
(197)
|
(331)
|
|
Total Other Income |
22
|
(8)
|
81
|
169
|
186
|
196
|
133
|
51
|
26
|
44
|
14
|
|
Pre-Tax Income |
(202)
N/A
|
(279)
-38%
|
(1 838)
-559%
|
(2 356)
-28%
|
(2 972)
-26%
|
(3 539)
-19%
|
(2 121)
+40%
|
(1 735)
+18%
|
(1 237)
+29%
|
(870)
+30%
|
(893)
-3%
|
|
Net Income | ||||||||||||
Tax Provision |
1
|
1
|
2
|
2
|
1
|
1
|
15
|
15
|
15
|
15
|
0
|
|
Income from Continuing Operations |
(202)
|
(278)
|
(1 837)
|
(2 355)
|
(2 971)
|
(3 538)
|
(2 106)
|
(1 720)
|
(1 223)
|
(855)
|
(893)
|
|
Income to Minority Interest |
1
|
2
|
7
|
7
|
9
|
8
|
1
|
(1)
|
(2)
|
(2)
|
0
|
|
Net Income (Common) |
(201)
N/A
|
(276)
-38%
|
(1 830)
-562%
|
(2 347)
-28%
|
(2 962)
-26%
|
(3 530)
-19%
|
(2 105)
+40%
|
(1 720)
+18%
|
(1 225)
+29%
|
(858)
+30%
|
(893)
-4%
|
|
EPS (Diluted) |
-0.11
N/A
|
-0.2
-82%
|
-1.35
-575%
|
-1.46
-8%
|
-1.82
-25%
|
-2.16
-19%
|
-1.25
+42%
|
-0.89
+29%
|
-0.63
+29%
|
-0.43
+32%
|
-0.46
-7%
|